The strongest association was observed for PM₂.₅, the microscopic particles measuring 2.5 micrometres or less in diameter. Because these particles are so small, they can penetrate deep into the lungs and, in some cases, cross into the bloodstream. Their chemical composition varies according to their source, but PM₂.₅ may contain metals, soot, organic compounds and other substances capable of triggering oxidative stress and chronic inflammation. Over time, these biological disturbances can damage DNA, alter immune responses and interfere with normal cellular repair. The new analysis found that every additional 10 micrograms of PM₂.₅ per cubic metre of air was associated with a 16.0 percent increase in the risk of all cancers combined.

The study also identified a J-shaped exposure–response relationship for PM₂.₅. In epidemiology, this pattern indicates that the risk does not rise in a simple straight line across all exposure levels. At lower concentrations, changes in risk may be relatively modest or difficult to distinguish, while at higher concentrations the curve turns upward more sharply. A J-shaped association can reflect biological thresholds, differences in population susceptibility or the effects of particularly intense pollution exposure. It may also emerge when background risks and other environmental factors vary across locations. The researchers used statistical models designed to capture this type of nonlinear pattern rather than assuming that every incremental increase in pollution carries exactly the same effect.

Ozone, commonly known as O₃, showed a different pattern. Unlike the protective ozone layer high in the atmosphere, ground-level ozone is a harmful pollutant formed when nitrogen oxides and volatile organic compounds react in sunlight. It is often more severe during hot, sunny conditions and can travel across administrative boundaries, making it difficult for individual cities to control. Ozone irritates the airways and can promote inflammation throughout the respiratory system. According to the study, each 10 micrograms per cubic metre increase in long-term ozone exposure was associated with a 4.23 percent rise in the risk of all cancers. The relationship was described as near-linear, meaning that the estimated risk increased more steadily as exposure rose.

Nitrogen dioxide, or NO₂, was associated with an 11.7 percent increase in all-cancer risk for every 10 micrograms per cubic metre increase in long-term exposure. The gas is generated primarily by fuel combustion, especially from vehicles, power plants and industrial activity. It can damage airway tissues directly and also contributes to the formation of ozone and secondary particles. Nitrogen dioxide is therefore both a pollutant in its own right and part of a wider atmospheric chemical system. Exposure is frequently highest near busy roads and in densely populated urban areas, where traffic emissions can create sharp differences in air quality from one neighbourhood to another.

When the researchers translated these relative risks into population-level estimates, the scale of the findings became considerably larger. PM₂.₅ exposure was estimated to be associated with approximately 8.82 million incident cancer cases worldwide during the study period. Ozone was linked to about 2.59 million cases, while nitrogen dioxide was associated with approximately 6.67 million cases. These figures represent attributable burdens calculated from population exposure and estimated risk relationships; they do not mean that every individual case can be traced to a single pollutant. Cancer is a multifactorial disease influenced by age, genetics, smoking, alcohol use, infections, diet, occupational hazards and access to medical care. Nevertheless, even a modest increase in risk can produce a substantial number of cases when it affects billions of people.

The researchers used distributed lag non-linear models, a method that can evaluate both delayed effects and nonlinear exposure patterns. Cancer often develops over years or decades, so the consequences of an exposure may not appear immediately after pollution levels rise. Distributed lag models allow investigators to examine how risk may accumulate across time rather than assigning all effects to the moment of exposure. The approach can also account for changing exposure levels, differences between locations and potential variations in the time required for environmental damage to contribute to disease. By combining these models with global cancer and pollution data, the study aimed to estimate not only relative risks but also the number of cases potentially linked to ambient air pollution.

One of the study’s most striking observations was the consistently higher attributable risk and burden among women for most malignancies. The analysis does not establish a single explanation for this difference, and the causes may vary by region and cancer type. Women and men can experience different occupational and household exposures, including pollution from cooking fuels, heating systems and poorly ventilated indoor environments. Biological differences in hormone regulation, immune function, body composition and pollutant metabolism could also influence susceptibility. In addition, patterns of healthcare access, diagnosis and cancer registration may affect the data. The finding highlights the importance of examining air pollution through a sex-specific lens rather than assuming that the same exposure produces identical outcomes in every population.

The results arrive as cities worldwide confront overlapping challenges from traffic emissions, industrial pollution, wildfires and climate-driven heat extremes. Fine particles can travel long distances, while hot weather can intensify ozone formation and increase the frequency of stagnant-air episodes. Reducing fossil-fuel combustion, improving public transport, tightening industrial standards, expanding clean household energy and monitoring pollution at neighbourhood scale could therefore deliver benefits beyond cardiovascular and respiratory health. The authors describe their estimates as an impetus for stronger public-health policies aimed at reducing the global cancer burden. Although the study is observational and its estimates depend on the quality of exposure data, cancer records and statistical assumptions, its vast geographic scope underscores a central message: cleaner air may be one of the most consequential cancer-prevention measures available to governments and communities.

Subject of Research: Global cancer burden associated with long-term exposure to ambient air pollution

Article Title: Global cancer burden associated with long-term exposure to ambient air pollution

Article References: Zhang, G., Li, Y., Li, A. et al. Global cancer burden associated with long-term exposure to ambient air pollution. Nat. Health (2026). https://doi.org/10.1038/s44360-026-00180-4

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s44360-026-00180-4

Keywords: Air pollution, PM₂.₅, ozone, nitrogen dioxide, cancer, public health, environmental epidemiology, global health, attributable burden

Air pollution is a complex mixture rather than a single chemical. Fine particulate matter, commonly known as PM2.5, can penetrate deep into the lungs and enter close contact with the bloodstream. Traffic emissions, industrial combustion, power generation, wildfires and other sources release particles and gases capable of triggering oxidative stress and inflammation. These biological responses have traditionally been studied through lung tissue, respiratory symptoms or population-level cancer statistics. The new research instead focuses on metabolites, the small molecules produced during normal cellular activity and altered when the body responds to environmental stress.

Metabolomics is often described as a molecular snapshot of physiology. Blood contains thousands of metabolites, including lipids, amino acids, sugars, hormones and products of inflammation. Because these compounds reflect the combined effects of genetics, diet, disease and environmental exposure, researchers can use advanced analytical techniques to search for patterns that distinguish individuals with different health risks. In this study, the investigators used blood-based metabolomic measurements to explore whether pollution exposure and lung cancer were linked through recognizable biochemical changes.

The study’s importance lies in its effort to connect three elements that are usually investigated separately: exposure to air pollution, biological disruption and the eventual development of lung cancer. Rather than treating air pollution as an external risk factor with no visible trace inside the body, the researchers looked for molecular signatures that could reveal how exposure is translated into disease-related processes. Such signatures may include changes in lipid metabolism, inflammatory pathways, oxidative damage and cellular energy production, all of which are relevant to the initiation and progression of cancer.

The Cancer Prevention Studies provide a powerful setting for this type of investigation. Large prospective cohorts can collect information about participants before disease develops, allowing researchers to compare earlier biological samples with later cancer outcomes. This design is especially valuable in lung cancer research, where smoking remains the dominant risk factor but does not explain every case. By studying participants over time, investigators can reduce the risk that the disease itself caused the metabolic changes observed in blood, a problem known as reverse causation.

The researchers combined metabolomic data with estimates of long-term air pollution exposure and information about lung cancer diagnoses. Exposure estimates in studies of this kind are generally derived from residential history and environmental models that approximate concentrations of pollutants over time. These estimates cannot reproduce every individual’s actual exposure, because people move, commute and spend time indoors or outdoors, but they allow scientists to investigate pollution patterns across large populations. Statistical models can then test whether particular metabolites or groups of metabolites are associated with both pollution exposure and cancer risk.

The emerging picture is not that a single “air pollution molecule” causes lung cancer. Instead, the findings point toward a network of biological responses. Pollutants can generate reactive oxygen species, unstable molecules that damage DNA, proteins and cell membranes. Inflammation can alter immune signaling and create tissue conditions favorable to abnormal cell growth. Changes in lipid metabolism may affect cell membranes and signaling molecules, while disrupted energy pathways can help stressed or transformed cells survive. A blood signature may therefore represent the cumulative effect of several interacting mechanisms rather than one isolated pathway.

This approach could eventually improve risk assessment, but the findings should not be interpreted as a ready-to-use blood test for diagnosing lung cancer or measuring an individual’s pollution burden. Metabolite levels are influenced by diet, medications, obesity, diabetes, smoking, physical activity and other exposures. A signature identified in one population must be replicated in independent cohorts and tested for its ability to predict disease beyond established factors such as age, smoking history and occupational exposure. Researchers must also determine whether the observed metabolic changes are causes of cancer, early consequences of disease or markers of susceptibility.

Even with those limitations, the study suggests a promising direction for environmental health research. Molecular signatures could help identify people whose biology is especially sensitive to polluted air, reveal which pollution sources are most harmful and clarify why some exposed individuals develop cancer while others do not. They may also guide prevention studies by showing whether reducing exposure, improving air quality or modifying inflammatory pathways produces measurable biological changes before disease appears.

The broader public-health message is immediate: air pollution is not merely an environmental nuisance but a source of biological stress that can leave detectable marks throughout the body. The study strengthens the case for policies that reduce fine-particle emissions and for continued research into lung cancer among never-smokers and other populations traditionally considered lower risk. By linking environmental exposure to blood chemistry and cancer biology, the work offers a more detailed explanation of how polluted air may contribute to one of the world’s most serious diseases—and provides a molecular roadmap for discovering ways to interrupt that process.

Subject of Research: Blood metabolomic signatures linking air pollution exposure to lung cancer risk.

Article Title: Blood metabolomic signatures linking air pollution to lung cancer in the Cancer Prevention Studies

Article References: Chow, S.S., Wang, Y., Sarnat, J.A. et al. “Blood metabolomic signatures linking air pollution to lung cancer in the Cancer Prevention Studies.” Nature Communications 17, 7255 (2026). https://doi.org/10.1038/s41467-026-75116-3

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41467-026-75116-3

Keywords: air pollution, lung cancer, metabolomics, blood biomarkers, PM2.5, environmental health, oxidative stress, inflammation, cancer prevention, epidemiology